Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 USD | +7.10% | +1.75% | -26.27% |
03-27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
03-27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.27% | 104M | |
-1.33% | 104B | |
+6.80% | 97.47B | |
+5.71% | 22.25B | |
-13.09% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.96% | 16.36B | |
+8.12% | 14.39B | |
+37.53% | 12.37B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- GlycoMimetics : Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating